Evaluate the Safety and Efficacy of AGE Serum in Post-menopausal Patients on Hormone Replacement Therapy Taking Glucagon-like Peptide-1 Agonist

Part of paid clinical trials in San Diego, California.

Sponsor
Goldman, Butterwick, Fitzpatrick and Groff
Study ID
NCT07558603
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Laxity; Skin

Eligibility Criteria

Sex
FEMALE
Age
45 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • On GLP1 plus HRT — DRUG
    AGE serum is a topical that contains a high concentration of 30% Proxylane and a synergistic blend of fruit-derived flavonoids (blueberry, pomegranate) and Cassia alata extract.
  • On GLP1 Only — DRUG
    AGE serum is a topical that contains a high concentration of 30% Proxylane and a synergistic blend of fruit-derived flavonoids (blueberry, pomegranate) and Cassia alata extract.

Study Details

The primary objective is to assess the safety and efficacy of the AGE Serum in improving the appearance of skin in post-menopausal subjects on HRT and non-HRT who are takingGLP-1 agonist therapy through the use of investigator assessments, subject questionnaires/assessments, photography, skin imaging, and reported adverse reactions.

Key Dates

Start date
Apr 20, 2026
Status verified
Apr 2026
Primary completion
Aug 30, 2026
Completion
Nov 30, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Group A= On GLP1 plus HRT
    Enrolled subjects will receive AGE Serum.
  • Sham Comparator: Group B= On GLP1 Only
    Enrolled subject will receive AGE serum

Primary Outcome Measure

Modified Griffith Scale [ Time Frame: Baseline, Week 6 and Week12 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
West Dermatology Research CenterSan DiegoCalifornia92121
Andrea Pacheco
[email protected]
858-657-1004
Freia Canals-Cistero
[email protected]
858-657-1004

Find similar trials in San Diego, CA

By research site
West Dermatology Research Center· San Diego, CA

Related Studies